Essential Ge Amersham Pharmacia Biotech Akta Fplc Monitor Upc-900 Series [9fn6rDN7]

High-Precision Online Monitor for Chromatography

The Essential Ge Amersham Pharmacia Biotech Akta Fplc Monitor Upc-900 Series [9fn6rDN7] is a cutting-edge device designed for precise online monitoring in liquid chromatography. This advanced instrument offers a comprehensive solution for the combined measurement of UV absorption, pH, and conductivity, ensuring accurate data collection for your research or industrial applications.

Robust Specifications and Advanced Features

The UPC-900 boasts a range of features that make it a standout choice in its category. With fixed wavelengths of 254, 280 nm (Hg lamp), or 214 nm (Zn lamp), and the flexibility to switch to other wavelengths like 313, 365, 405, 436, and 546 nm using filter change, it provides versatile analysis options. The inclusion of two alternative flow cells with pathlengths of 2 mm and 5 mm further enhances its adaptability. Its fast response time, high accuracy, and reproducibility, along with low dead volume flow cells, ensure reliable and efficient monitoring. The self-test and self-calibration capabilities add to its reliability, while the ability to connect flow cells close together minimizes band broadening and time delay between detectors.

Practical Applications and Target Audience

The AKTA FPLC Monitor UPC-900 is an ideal tool for researchers and professionals in various fields, including pharmaceuticals, biotechnology, and environmental analysis. Its precise measurements and versatile features make it suitable for a wide range of applications, such as protein purification, drug discovery, and water quality testing. By offering reliable monitoring solutions, the UPC-900 streamlines workflows and enhances the accuracy of experiments, ultimately saving time and resources. With a 30-day warranty and certification of genuine product status, you can trust in the quality and reliability of the UPC-900, ensuring a smooth and efficient experience in your research endeavors.